Filter by Category
Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Policy & Public
Food & Nutrition
Entrepreneurship
Energy & Environment
Emerging Technologies
Consumer Goods
Biomanufacturing, Chemicals & Materials
Funding & Investments
Health & Medicine
Agriculture
Subscribers Only
Access The Future of Epidemic Prevention Lies in Wastewater Analysis For Free!
Access Now
-

The Future of Epidemic Prevention Lies in Wastewater Analysis

September 17, 2024
Published
-
September 17, 2024
Subscribers Only
Access Profluent launches to design new proteins with generative AI For Free!
Access Now
-

Profluent launches to design new proteins with generative AI

January 26, 2023
Published
-
January 26, 2023
Subscribers Only
Access Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies For Free!
Access Now
-

Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies

January 9, 2023
Published
-
January 9, 2023
Subscribers Only
Access Twist Bioscience and Astellas Enter into Multitarget Antibody Discovery Research Collaboration For Free!
Access Now
-

Twist Bioscience and Astellas Enter into Multitarget Antibody Discovery Research Collaboration

January 9, 2023
Published
-
January 9, 2023
Subscribers Only
Access ReCode Therapeutics Announces Strategic Collaboration with AskBio to Explore Single Vector Gene-Editing Platform For Free!
Access Now
-

ReCode Therapeutics Announces Strategic Collaboration with AskBio to Explore Single Vector Gene-Editing Platform

January 9, 2023
Published
-
January 9, 2023
Subscribers Only
Access Synlogic Announces Achievement of Proof of Concept for SYNB8802 in Enteric Hyperoxaluria Based on Urinary Oxalate Lowering in Phase 1b Study For Free!
Access Now
-

Synlogic Announces Achievement of Proof of Concept for SYNB8802 in Enteric Hyperoxaluria Based on Urinary Oxalate Lowering in Phase 1b Study

December 19, 2022
Published
-
December 19, 2022
Subscribers Only
Access Gamida Cell Announces Closing of $25 Million Financing With Highbridge For Free!
Access Now
-

Gamida Cell Announces Closing of $25 Million Financing With Highbridge

December 12, 2022
Published
-
December 12, 2022
Subscribers Only
Access Touchlight receives grant to advance rapid, scalable and thermostable doggybone DNA vaccine platform For Free!
Access Now
-

Touchlight receives grant to advance rapid, scalable and thermostable doggybone DNA vaccine platform

November 29, 2022
Published
-
November 29, 2022
Subscribers Only
Access BigHat Biosciences Announces Research Collaboration with Merck For Free!
Access Now
-

BigHat Biosciences Announces Research Collaboration with Merck

November 29, 2022
Published
-
November 29, 2022
Subscribers Only
Access Synlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3 For Free!
Access Now
-

Synlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3

October 18, 2022
Published
-
October 18, 2022
Subscribers Only
Access Arsenal Biosciences Announces Joint Discovery Collaboration with Genentech to Identify Features of Successful T-Cell Therapies for Oncology For Free!
Access Now
-

Arsenal Biosciences Announces Joint Discovery Collaboration with Genentech to Identify Features of Successful T-Cell Therapies for Oncology

September 28, 2022
Published
-
September 28, 2022
Subscribers Only
Access Persephone Biosciences Announces First Participant Enrolled in the ARGONAUT Study of Gut Microbiome-Linked Immune Modulation in Cancer Treatment Response For Free!
Access Now
-

Persephone Biosciences Announces First Participant Enrolled in the ARGONAUT Study of Gut Microbiome-Linked Immune Modulation in Cancer Treatment Response

September 27, 2022
Published
-
September 27, 2022
Subscribers Only
Access Beam Therapeutics Presents First In Vivo Data Demonstrating Potential of Multiplex Base Editing Approach to Target Disease Drivers of Chronic Hepatitis B Infection For Free!
Access Now
-

Beam Therapeutics Presents First In Vivo Data Demonstrating Potential of Multiplex Base Editing Approach to Target Disease Drivers of Chronic Hepatitis B Infection

September 19, 2022
Published
-
September 19, 2022
Subscribers Only
Access Capstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering For Free!
Access Now
-

Capstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering

September 15, 2022
Published
-
September 15, 2022
Subscribers Only
Access Think Bioscience Raises $17M in Oversubscribed Seed Round to Develop Small Molecule Drugs that Hit Undruggable Proteins For Free!
Access Now
-

Think Bioscience Raises $17M in Oversubscribed Seed Round to Develop Small Molecule Drugs that Hit Undruggable Proteins

September 6, 2022
Published
-
September 6, 2022
Subscribers Only
Access Codagenix Announces Award with the US Department of Defense for Development of Balanced, Tetravalent Dengue Vaccine For Free!
Access Now
-

Codagenix Announces Award with the US Department of Defense for Development of Balanced, Tetravalent Dengue Vaccine

August 19, 2022
Published
-
August 19, 2022
Subscribers Only
Access Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks For Free!
Access Now
-

Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks

August 15, 2022
Published
-
August 15, 2022
Subscribers Only
Access Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform For Free!
Access Now
-

Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform

July 16, 2022
Published
-
July 16, 2022
Subscribers Only
Access Synlogic Initiates Phase 1 Study of SYNB1353 for the Treatment of Homocystinuria (HCU) For Free!
Access Now
-

Synlogic Initiates Phase 1 Study of SYNB1353 for the Treatment of Homocystinuria (HCU)

July 12, 2022
Published
-
July 12, 2022
Subscribers Only
Access Epic Bio, Founded by CRISPR Pioneer, Launches to Revolutionize Genetic Medicine With Epigenetic Engineering For Free!
Access Now
-

Epic Bio, Founded by CRISPR Pioneer, Launches to Revolutionize Genetic Medicine With Epigenetic Engineering

July 12, 2022
Published
-
July 12, 2022
Subscribers Only
Access Twist Bioscience Opens New Twist Boston Location to Expand Antibody Discovery Capacity For Free!
Access Now
-

Twist Bioscience Opens New Twist Boston Location to Expand Antibody Discovery Capacity

July 7, 2022
Published
-
July 7, 2022
Cookie Policy

Lorem ipsum dolor sit amet, consectetur adip elit. Donec posuere dolor massa, pellentesque aliquam nisl facilisis sed.

ManageAccept
Copyright SynBioBeta 2024